Skip to main content
. 2015 Mar;7(3):400–406. doi: 10.3978/j.issn.2072-1439.2015.01.03

Figure 1.

Figure 1

Compound K activates p53 in lung cancer cells. (A) H460 and A549 cells were treated with CK at indicated doses for 18 hr and the cells were lysed and subjected to western blot analysis; (B) H460 and A549 cells were treated with 20 µM CK for indicated duration and subjected to western blot analysis.